4//SEC Filing
Boxer Capital Management, LLC 4
Accession 0000895345-24-000458
CIK 0001863127other
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 8:49 PM ET
Size
8.4 KB
Accession
0000895345-24-000458
Insider Transaction Report
Form 4
Transactions
- Disposition to Issuer
Common Stock
2024-10-18−2,000,000→ 4,448,359 total(indirect: See footnote) - Award
Pre-Funded Warrant (right to purchase)
2024-10-18+2,000,000→ 2,705,280 total(indirect: See footnote)Exercise: $0.00→ Common Stock (2,000,000 underlying)
Footnotes (3)
- [F1]On October 18, 2024, Boxer Capital, LLC ("Boxer") entered into an exchange agreement with the Issuer, pursuant to which Boxer agreed to exchange 2,000,000 shares of the Issuer's Common Stock for a pre-funded warrant to purchase up to 2,000,000 shares of Common Stock (the "Pre-Funded Warrant"). The Pre-Funded Warrant was issued on October 22, 2024.
- [F2]These securities are beneficially owned indirectly by Boxer Capital Management, LLC ("BCM") as the investment manager of Boxer. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- [F3]The Pre-Funded Warrant has no expiration date and is exercisable at any time after the date of issuance. A holder of the Pre-Funded Warrant may not exercise the Pre-Funded Warrant if the holder, together with other persons whose beneficial ownership is aggregated for purposes of Section 13 or Section 16 under the Securities Exchange Act of 1934, as amended, would beneficially own more than 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise.
Documents
Issuer
Tyra Biosciences, Inc.
CIK 0001863127
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0002018299
Filing Metadata
- Form type
- 4
- Filed
- Oct 21, 8:00 PM ET
- Accepted
- Oct 22, 8:49 PM ET
- Size
- 8.4 KB